ICD-10 Codes Don't Tell the Full Story About Heart Failure | AHA Scientific Sessions
Ejection fraction is a key factor in how clinicians diagnose, classify and treat heart failure. But you might not know it if you depended solely on ICD-10 codes.
Tyler J. Gluckman, M.D., medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, presented research findings this weekend at the American Heart Association Scientific Sessions meeting in Philadelphia about how well the ICD-10 codes used for billing and other purposes reflect ejection fraction.
Gluckman and his colleagues found a large variation in the ejection fraction among two of the most commonly used ICD-10 codes for heart failure, hypertensive heart disease with heart failure and hypertensive heart disease with heart failure and chronic kidney disease.
Muthu Vaduganathan Gives Insights on the Cost Effectiveness of SGLT2 Inhibitors
March 29th 2024In this second part of a two-part video series, MHE editors spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the cost effectiveness of SGLT2 inhibitors.
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
Stephen Greene, MD, Gives Insight on the New Heart Failure Drug Sotagliflozin
February 20th 2024Stephen Greene, MD, of Duke University School of Medicine, explains that Inpefa (sotagliflozin), a recently FDA-approved dual SGLT-1 and SGLT-2 inhibitor, aims to reduce cardiovascular death, heart failure, hospitalizations, or urgent heart failure visits among patients with heart failure, chronic kidney disease, type 2 diabetes, and another cardiovascular risk factor.
Read More
